Study of sorafenib and radiation therapy for advanced hepatocellular carcinoma with portal vein thrombosis - Sorafenib and radiation therapy for hepatocellular carcinoma

Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine0 个研究点目标入组 6 人开始时间: 2012年6月16日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Refractory pleural effusion or ascites 2) Encephalopathy 3) Concurrent disease a) Serious hypertension b) Severe heart disease c) Acute myocardial infarction within 6 months prior to inclusion d) Active double cancer e) Severe mental disorder f) Allergic reaction to iodine contrast material g) Severe drug allergy 4) Pregnant and lactating females; females of childbearing age unless using effective contraception 5) Patients who are concluded to be inappropriate to participate in this study by their physicians

发起方

Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine